ONLINE MASTERCLASS
Project, Program, and Portfolio Risk Analysis Online Masterclass
4 Half-day LIVE Online Masterclass
- Location: ONLINE
- June 16-19, 2025
- 10:00–14:00 EDT (East Coast)
- 7:00–11:00 PDT (West Coast)
- 16:00–20:00 CEST (EU)
-
Course Leader: Dr. Richard Bayney,
President & Founder of Project & Portfolio Value Creation.
4 HALF-DAY
INTERNATIONAL MASTERCLASS
MASTERCLASS OVERVIEW
Learn how to quantify and manage risk at project, program, and portfolio levels. Assess the extent to which multiple indications and/or lines of therapy affect program risk and valuation. Quantify the likelihood that your R&D pipeline portfolio and commercial portfolio will meet annual corporate targets
AUDIENCE
This masterclass is particularly interesting for industry
professionals across Pharma, Biotech, Medical Devices, and Consumer Care involved in:
- Project, Program & Portfolio Management
- Research
- Clinical Development
- Resource Management
- Forecasting & Competitive Intelligence
- Licensing & Business Development
- Finance
- Commercialization
- Consultants are NOT permitted to attend
MEET THE
Masterclass leader
Dr. Richard Bayney is President of Project & Portfolio Value Creation (PPVC), a consulting boutique that he founded in 2008 which provides training and education in Project, Program, Portfolio, Resource, and Risk Management as well as Business, Strategic, Portfolio, and Scenario Planning services. He is an adjunct faculty member at the University of Pennsylvania.
Dr. Bayney is a 23-year veteran of the Pharmaceutical & Biotechnology industry at Merck & Co., Bayer Corp. and AG, Bristol-Myers Squibb, and Johnson & Johnson Pharmaceutical Research & Development. In his previous position at Johnson & Johnson, Richard was Vice President, Portfolio Management & Decision Analysis. Dr. Bayney obtained his M.Sc. and Ph.D. from the University of London, MBA from Columbia University, and PMP from the Project Management Institute.
TOPIC SNEAK PEEK
- Quantification of project risk using risk decomposition and Decision Trees
- Quantification of program risk using correlated project risks and Decision Trees
- Quantification of portfolio risk using simulation
- Generation of strategic alternatives for Clinical Development, Registration, and Commercialization
- Selecting dominant strategies based on eNPV
- Accounting for commercial uncertainty in the product portfolio using simulation
- Accounting for risk and commercial uncertainty in the pipeline portfolio
- Quantifying the likelihood of meeting corporate growth targets (Long Range Plan)
Industry Pioneers Attending From
Testimonials
5/5
It was truly my pleasure to be a part of this event, and I look forward to implementing the newfound wisdom and learnings into my daily work!
Guillermo Ducay de la Riva
Head of Legal and Senior Key Account Manager, Tiefenbacher Group
5/5
Conferences like these offer a unique opportunity for industry professionals to exchange knowledge, network, and stay abreast of the latest trends and developments shaping the generics market. Hopefully, you gained valuable insights and connections to further enhance your work in this field.
Ana Gavaldá
Founder & CEO, Annion
5/5
Asking WHY? is a good way of staying hashtag#agile alongside career maturity. Why Summits encourages being curious, creating very open and inspiring atmosphere for professional talks. This time at 2nd PPM for Generics I was delighted to synchronize watches with passionate experts in Portfolio, Project and Business Development to a) see that the outstanding challenges and questions are the same (apart from war, of course) and b) what's more important - to get insights and ideas for future hashtag#growth!
Anna Shestakova, MBA
Portfolio Development & Launch Manager, Stada
5/5
It was a delight to participate as a speaker at the 2nd Global Project Management, Portfolio Planning & Partnerships for Generics conference hosted by Why Summits in Munich.
The conference also provided a wonderful opportunity to connect with many brilliant minds in the pharmaceutical generic sector, allowing me to expand my network with numerous talented and knowledgeable professionals.
Ahmed Saeed Khalil
Regulatory Special Projects Lead - Global RA, Sandoz
5/5
The careful selection of attendees made for a great exchange of ideas and best practices as well as many insightful conversations, especially at the afternoon roundtables. Looking forward to the next round at Why Summit in Munich 2025!
Christine Weitbrecht
Former Denk Pharma
5/5
Last week there was an interesting and unique pharma conference in Munich: Global Project Management, Portfolio planning and Partnership for Generics. A shout-out to everyone that participated and attended my Lego workshop through which we explained the importance of managing our stakeholders, how we effectively communicate with them and how to make a team understand its mission and vision to motivate them and give them purpose. It was great being part of this conference and getting to meet pioneers of our field.
Konstantinos Chatzivarytis
Sr. Manager Practice Lead Agile Coach, Pfizer
Everything you need to know about this masterclass in one spot.
Check out our masterclass overview and agenda for this Masterclass.
REGISTRATION
Masterclass
4 HALF-DAY ONLINE Ticket | June 16-19, 2025
$
2099
-
Access to Decision Analysis & Portfolio Management Masterclass with Industry Veteran Dr. Richard Bayney.
-
Individual consultancy with the trainer
-
Electronic copy of trainer's textbook
-
Certificate of completion issued by the trainer
